Skip to main navigation Skip to search Skip to main content

A randomized controlled study of intravenous fluid in acute ischemic stroke

  • on behalf of the IVIS Study Group
  • Chulalongkorn University
  • King Chulalongkorn Memorial Hospital
  • Bhumibol Adulyadej Hospital
  • Thammasat University
  • Chiang Mai University
  • Khon Kaen University
  • David Geffen School of Medicine at UCLA

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

Objective To compare the outcome of patients with acute ischemic stroke who received or did not receive intravenous fluid. Patients and methods This study was a prospective, multicenter, randomized, open-label trial with blinded outcome assessment. We enrolled acute ischemic stroke patients without dehydration aged between 18 and 85 years with NIH Stroke Scale score (NIHSS) score from 1 to 18 who presented within 72 h after onset. Patients were randomly assigned to receive 0.9% NaCl solution 100 ml/h for 3 days or no intravenous fluid. Results On the interim unblinded analysis of the safety data, significant excess early neurological deterioration was observed among patients in the non-intravenous fluid group. Therefore, the study was prematurely discontinued after enrollment of 120 patients, mean age 60 years, 56.6% male. Early neurological deterioration (increased NIHSS ≥3 over 72 h) not of metabolic or hemorrhagic origin was observed in 15% of the non-IV fluid group and 3.3% of the IV fluid group (p = 0.02). Predictors of neurological deterioration were higher NIHSS score, higher plasma glucose, and increased pulse rate. There was no difference in the primary efficacy outcome, NIHSS ≤ 4 at day 7, 83.3% vs 86.7%, p = 0.61 or secondary efficacy outcomes. Conclusion Administration of 0.9% NaCl 100 ml/h for 72 h in patients with acute ischemic stroke is safe and may be associated with a reduced risk of neurological deterioration. These study findings support the use of intravenous fluid in acute ischemic stroke patients with NIHSS less than 18 who have no contraindications.

Original languageEnglish
Pages (from-to)98-103
Number of pages6
JournalClinical Neurology and Neurosurgery
Volume161
DOIs
Publication statusPublished - Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Intravenous fluid
  • Ischemic stroke
  • Progressive stroke
  • Stroke in evolution

Fingerprint

Dive into the research topics of 'A randomized controlled study of intravenous fluid in acute ischemic stroke'. Together they form a unique fingerprint.

Cite this